Stella Pharma Corporation

TSE:4888 Stock Report

Market Cap: JP¥12.6b

Stella Pharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure5.9yrs

Recent management updates

Recent updates


CEO

Stella Pharma has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Toshimitsu Hayashi
GM of Pharmaceutical Affairs & Clinical Development Department and Director1.9yrsno data0.0064%
¥ 810.6k
Takahiro Kido
GM of Corporate Planning Department & Director1.9yrsno data0.0029%
¥ 364.2k
Kazumitsu Yabu
Director20.9yrsno data0.016%
¥ 2.0m
Kiyoshi Nagata
Director5.9yrsno datano data
Tomoyuki Asano
Chairman16.9yrsno data0.0064%
¥ 810.6k
Koki Uehara
President & Representative Director11.5yrsno data0.022%
¥ 2.8m
Masaya Onishi
Independent Outside Director5.9yrsno datano data
Kohei Tsujii
Independent Outside Director5.9yrsno datano data

5.9yrs

Average Tenure

49.5yo

Average Age

Experienced Board: 4888's board of directors are considered experienced (5.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.